Partial trypsin digestion as an indicator of mis-folding of mutant alanine:glyoxylate aminotransferase and chaperone effects of specific ligands.: Study of a spectrum of missense mutants

被引:29
作者
Coulter-Mackie, M. B. [1 ,2 ,3 ]
Lian, Q. [1 ]
机构
[1] Univ British Columbia, Children & Womens Hlth Ctr BC, Dept Pediat, Vancouver, BC V6H 3V4, Canada
[2] Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC V6H 3V4, Canada
[3] Univ British Columbia, Dept Med Genet, Vancouver, BC V6H 3V4, Canada
基金
加拿大健康研究院;
关键词
hyperoxaluria; mutation; mis-folding; pharmacological chaperone; alanine : glyoxylate aminotransferase;
D O I
10.1016/j.ymgme.2008.03.010
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Alanine:glyoxylate aminotransferase (AGT) is a liver peroxisomal enzyme whose deficiency results in primary hyperoxaluria type 1 (PH1). More than 75 PHI mutations are now documented in the AGT gene (AGXT), of which about 50% are missense. We have previously demonstrated that many such mutants expressed by transcription/translation are subject to generalized degradation by the proteasome and a specific limited trimming by an endogenous ATP-independent protease activity. Here, we report the results of partial digestion using trypsin as a mimic for the endogenous non-proteasomal protease and the use of N-terminal protein sequencing to determine the sensitive site. Partial trypsin digestion also provided an indicator of proper folding of the mutant enzyme. For selected mutations the sensitivity to trypsin could be ameliorated by addition of pyridoxal phosphate or aminooxy acetic acid as specific pharmacological chaperones. (c) 2008 Elsevier Inc. All rights reserved
引用
收藏
页码:368 / 374
页数:7
相关论文
共 48 条
[21]   In and out of the ER: Protein folding, quality control, degradation, and related human diseases [J].
Hebert, Daniel N. ;
Molinari, Maurizio .
PHYSIOLOGICAL REVIEWS, 2007, 87 (04) :1377-1408
[22]   Aminooxy acetic acid: A selective inhibitor of alanine:glyoxylate aminotransferase and its use in the diagnosis of primary hyperoxaluria type I [J].
Horvath, VAP ;
Wanders, RJA .
CLINICA CHIMICA ACTA, 1995, 243 (02) :105-114
[23]   Protein degradation in mitochondria [J].
Käser, M ;
Langer, T .
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY, 2000, 11 (03) :181-190
[24]   Binding of pyridoxal 5′-phosphate to the heme protein human cystathionine β-synthase [J].
Kery, V ;
Poneleit, L ;
Meyer, JD ;
Manning, MC ;
Kraus, JP .
BIOCHEMISTRY, 1999, 38 (09) :2716-2724
[25]   CLEAVAGE OF STRUCTURAL PROTEINS DURING ASSEMBLY OF HEAD OF BACTERIOPHAGE-T4 [J].
LAEMMLI, UK .
NATURE, 1970, 227 (5259) :680-+
[26]   Functional synergism between the most common polymorphism in human alanine:glyoxylate aminotransferase and four of the most common disease-causing mutations [J].
Lumb, MJ ;
Danpure, CJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (46) :36415-36422
[27]  
MATSUDAIRA P, 1987, J BIOL CHEM, V262, P10035
[28]   A SERINE-TO-PHENYLALANINE SUBSTITUTION LEADS TO LOSS OF ALANINE - GLYOXYLATE AMINOTRANSFERASE CATALYTIC ACTIVITY AND IMMUNOREACTIVITY IN A PATIENT WITH PRIMARY HYPEROXALURIA TYPE-1 [J].
MINATOGAWA, Y ;
TONE, S ;
ALLSOP, J ;
PURDUE, PE ;
TAKADA, Y ;
DANPUR, CJ ;
KIDO, R .
HUMAN MOLECULAR GENETICS, 1992, 1 (08) :643-644
[29]   Implications of genotype and enzyme phenotype in pyridoxine response of patients with type I primary hyperoxaluria [J].
Monico, CG ;
Olson, JB ;
Milliner, DS .
AMERICAN JOURNAL OF NEPHROLOGY, 2005, 25 (02) :183-188
[30]   Pyridoxine effect in type I primary hyperoxaluria is associated with the most common mutant allele [J].
Monico, CG ;
Rossetti, S ;
Olson, JB ;
Milliner, DS .
KIDNEY INTERNATIONAL, 2005, 67 (05) :1704-1709